We’re open access.
That means everyone, everywhere can read, redistribute, and reuse your research without cost: colleagues, patients, policy makers, journalists, the next generation of researchers. Your work will have the maximum possible impact.
Experts around the world advise us and publish with us.
From New York to Rwanda, from Germany to Singapore, academics at the forefront of their specialties review, act as academic editors, and publish with us.
We’re developing new ways of communicating research.
PLOS now has a diverse range of websites including:
- PLOS Journals – established high-quality peer-reviewed publications
- PLOS Currents – publishing peer-reviewed research in as little as 24 hours from acceptance
- PLOS Blogs – a network for discussing science and medicine in public
- PLOS Collections – content on a topic that has been collected from one or more PLOS titles
- PLOS Hubs – aggregating content that has been previously published in a variety of sources and adding value to content through links to further relevant information and data
We’ve also introduced new user features such as article-level metrics to help people understand the impact of research on the broader community, a sophisticated search engine, and commenting/rating mechanisms to encourage interaction and debate around research. We also have applications for the iPhone and iPad which were developed for us by members of the IT community.
Papers in PLOS journals get noticed.
Reuters, BBC, and The New York Times, to name but a few, all regularly cover PLOS publications. Not to mention all the blogs that highlight our content.
We’re compliant with all funders’ public access policies.
We immediately deposit your work in PubMed Central upon publication, as required for example by the NIH, the Wellcome Trust, and the European Research Council.
PubMed Central is a public archive created by the National Center for Biotechnology Information of the National Library of Medicine in the United States; it is not itself a publisher. It provides a single free repository for the published literature, and many publishers deposit content there (some after an embargo, such as the Proceedings of the National Academy of Sciences USA and Rockefeller University Press). The content in PubMed Central is also integrated with some of the databases that are maintained by the National Center for Biotechnology Information.